Compass Therapeutics (CMPX) Operating Margin (2024)
Compass Therapeutics (CMPX) reported Operating Margin of 1770.0% for Q2 2024.
Compass Therapeutics (CMPX) Operating Margin (2024) Analysis & Trends
Compass Therapeutics (CMPX) has 1 years of Operating Margin data on file, last reported at 1770.0% in Q2 2024.
- For the quarter ending Q2 2024, Operating Margin changed N/A year-over-year to 1770.0%; the trailing twelve-month figure through Jun 2025 stood at 7981.76% (down 149541.0% YoY), and the FY2024 full-year result was 6661.76%, changed N/A from the prior year.
- Operating Margin was little changed at 1770.0% in Q2 2024.
- In the past five years, Operating Margin ranged from a high of 1770.0% in Q2 2024 to a low of 1770.0% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Compass Therapeutics | 395.17 Mn | 200.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -1,770.00% |